FAKTOR-OPTIONSSCHEIN - AMGEN | Market Closed - Deutsche Boerse AG 03:43:04 2024-05-17 pm EDT | ||
| 2.04 EUR | +2.00% |
|
| Current month | -28.42% | ||
| 1 month | -33.98% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-17 | 2.04 | +2.00% |
| 24-05-16 | 2 | +2.04% |
| 24-05-15 | 1.96 | -6.22% |
| 24-05-14 | 2.09 | -2.34% |
| 24-05-13 | 2.14 | +2.39% |
Delayed Quote Deutsche Boerse AG
Last update May 17, 2024 at 03:43 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SB0QMA |
| ISIN | DE000SB0QMA7 |
| Date issued | 2020-06-04 |
| Strike | 223.6 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 8.98 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9.27 € |
|---|---|
| Lowest since issue | 1.96 € |
| Spread | 0.01 € |
| Spread % | 0.49% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
312.5
USD
Average target price
314.1
USD
Spread / Average Target
+0.51%
- Stock Market
- Certificates
- Certificat
